Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
6.75
-0.04 (-0.59%)
May 14, 2025, 3:18 PM - Market open
Global Medical REIT Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Global Medical REIT stock have an average target of 10.25, with a low estimate of 9.00 and a high estimate of 11.75. The average target predicts an increase of 51.85% from the current stock price of 6.75.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Global Medical REIT stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +33.33% | May 8, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Berenberg | Berenberg | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +74.07% | Oct 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +48.15% | May 13, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +62.96% | May 8, 2023 |
Financial Forecast
Revenue This Year
148.87M
from 138.76M
Increased by 7.29%
Revenue Next Year
154.40M
from 148.87M
Increased by 3.71%
EPS This Year
0.09
from 0.01
Increased by 646.40%
EPS Next Year
0.04
from 0.09
Decreased by -55.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 161.0M | 167.9M | 168.1M | |
| Avg | 148.9M | 154.4M | 158.2M | |
| Low | 138.1M | 142.1M | 147.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 16.0% | 12.8% | 8.9% | |
| Avg | 7.3% | 3.7% | 2.4% | |
| Low | -0.4% | -4.5% | -4.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.17 | 0.12 | 0.09 |
| Avg | 0.09 | 0.04 | 0.09 |
| Low | 0.05 | -0.05 | 0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,266.0% | 25.8% | 131.6% |
| Avg | 646.4% | -55.6% | 125.0% |
| Low | 298.4% | - | 116.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.